Please login to the form below

Not currently logged in
Email:
Password:

Ganymed Pharmaceuticals

This page shows the latest Ganymed Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Astellas agrees €800m deal to buy Belgian biotech Ogeda

Astellas agrees €800m deal to buy Belgian biotech Ogeda

This is the second major deal for Astellas in a few months, following a $1.4bn acquisition of Germany's Ganymed Pharmaceuticals that gave it a gastric cancer antibody (IMAB362) in

Latest news

  • Astellas buys Ganymed to boost immuno-oncology pipeline Astellas buys Ganymed to boost immuno-oncology pipeline

    Astellas has agreed to pay 422m upfront to buy Ganymed Pharmaceuticals, a German biopharma company specialising in antibody-based cancer drugs. ... If all goes according to plan, Ganymed's shareholders could pick up an additional 860m in milestones,

  • Hexal co-founders continue biotech buy up

    The Struengmanns already hold stakes in German biotechnology companies including 4SC and Ganymed Pharmaceuticals, which is developing monoclonal antibody therapeutics to fight solid cancer tumours.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics